Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Encompass Health Corp Director's Dealing 2023

Mar 2, 2023

30484_dirs_2023-03-02_93bad252-591f-494d-a14a-8537bfe54733.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Encompass Health Corp (EHC)
CIK: 0000785161
Period of Report: 2023-03-01

Reporting Person: Tarr Mark J (Director, President & CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-01 Non-qualified Stock Option (Right to Buy) $56.21 A 49498 Acquired 2033-03-01 Encompass Health Common Stock (49498) Direct

Footnotes

F1: The option becomes exercisable in equal annual installments over a three-year period commencing March 1, 2024.